In July 2017, the U.S. Drug Enforcement Administration (DEA) approved our upcoming Phase 1 study on the effect of MDMA on startle testing in healthy volunteers by providing a Schedule I research license for a scientist working with Principal Investigator Barbara Rothbaum, Ph.D., at the Emory University study site. The official site initiation visit will take place in August 2017. This study will be followed by another study exploring the combination of MDMA with Prolonged Exposure in PTSD patients. Learn more…
